Free Trial

MongoDB (MDB) Stock Forecast & Price Target

MongoDB logo
$245.63 +0.63 (+0.26%)
(As of 12/20/2024 05:45 PM ET)

MongoDB - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
5
Buy
22

Based on 29 Wall Street analysts who have issued ratings for MongoDB in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 29 analysts, 2 have given a sell rating, 5 have given a hold rating, 21 have given a buy rating, and 1 has given a strong buy rating for MDB.

Consensus Price Target

$366.14
49.06% Upside
According to the 29 analysts' twelve-month price targets for MongoDB, the average price target is $366.14. The highest price target for MDB is $430.00, while the lowest price target for MDB is $220.00. The average price target represents a forecasted upside of 49.06% from the current price of $245.63.
Get the Latest News and Ratings for MDB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for MongoDB and its competitors.

Sign Up

MDB Analyst Ratings Over Time

TypeCurrent Forecast
12/23/23 to 12/22/24
1 Month Ago
11/23/23 to 11/22/24
3 Months Ago
9/24/23 to 9/23/24
1 Year Ago
12/23/22 to 12/23/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
21 Buy rating(s)
19 Buy rating(s)
20 Buy rating(s)
22 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
2 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$366.14$336.54$337.56$432.44
Forecasted Upside49.06% Upside1.22% Upside20.78% Upside6.13% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

MDB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MDB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

MongoDB Stock vs. The Competition

TypeMongoDBComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.72
2.69
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside49.06% Upside265.04% Upside14.53% Upside
News Sentiment Rating
Neutral News

See Recent MDB News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/18/2024Tigress Financial
3 of 5 stars
 Boost TargetBuy ➝ Buy$400.00 ➝ $430.00+65.24%
12/17/2024Rosenblatt Securities
3 of 5 stars
B. Abernethy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$350.00+31.76%
12/16/2024Citigroup
3 of 5 stars
 Boost TargetBuy ➝ Buy$400.00 ➝ $430.00+57.53%
12/16/2024Monness Crespi & Hardt
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. White
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Sell$220.00-17.66%
12/12/2024Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Beynon
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageStrong-Buy ➝ Neutral$300.00+0.94%
12/11/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Outperform ➝ Market Outperform$380.00 ➝ $380.00+25.35%
Vladimir Lenin was right… (Ad)

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.
12/11/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$325.00 ➝ $385.00+27.00%
12/10/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$350.00 ➝ $425.00+43.00%
12/10/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$320.00 ➝ $400.00+32.02%
12/10/2024DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$340.00 ➝ $405.00+31.92%
12/10/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$350.00 ➝ $400.00+30.29%
12/10/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$350.00 ➝ $400.00+27.18%
12/10/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$340.00 ➝ $390.00+11.39%
12/10/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$295.00 ➝ $350.00-0.04%
12/10/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$380.00 ➝ $390.00+11.39%
12/10/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$275.00 ➝ $320.00-8.61%
12/10/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$425.00 ➝ $425.00+21.38%
12/10/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$335.00 ➝ $415.00+18.53%
12/10/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$375.00 ➝ $400.00+14.24%
12/10/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$340.00 ➝ $350.00-0.04%
12/9/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$325.00 ➝ $360.00+4.83%
12/5/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$330.00 ➝ $375.00+9.87%
12/2/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$315.00 ➝ $400.00+21.42%
10/17/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Ives
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/30/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$358.00 ➝ $360.00+25.40%
8/30/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$250.00 ➝ $275.00-2.22%
8/30/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$300.00 ➝ $350.00+42.44%
6/3/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
H. Ma
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral
3/19/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral ➝ Sell$410.00 ➝ $295.00-17.22%
11/8/2023Capital One Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeEqual Weight ➝ Overweight$427.00+15.71%
9/5/2023Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$435.00 ➝ $484.00+22.66%
6/26/202358.com
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
6/26/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
6/26/202322nd Century Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
6/2/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Ader
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
3/10/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$305.00 ➝ $250.00+19.29%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:36 AM ET.


Should I Buy MongoDB Stock? MDB Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, December 12, 2024. Please send any questions or comments about these MongoDB pros and cons to contact@marketbeat.com.

MongoDB
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in MongoDB, Inc.:

  • The stock price recently reached $350.13, reflecting a 2.0% increase, indicating positive market sentiment and potential for further growth.
  • MongoDB, Inc. reported a quarterly revenue of $478.11 million, surpassing analysts' expectations, which demonstrates strong demand for its database platform.
  • Analysts have a consensus rating of "Moderate Buy" with a target price of $345.71, suggesting that many believe the stock is undervalued and has room for appreciation.
  • Recent upgrades from major financial institutions, including Bank of America and Citigroup, have raised target prices significantly, indicating confidence in the company's future performance.
  • The company has a solid current ratio of 5.03, which indicates strong liquidity and the ability to cover short-term obligations, making it a safer investment.

MongoDB
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in MongoDB, Inc. for these reasons:

  • MongoDB, Inc. has a negative PE ratio of -115.94, which suggests that the company is currently not profitable, raising concerns about its long-term viability.
  • Insider selling has been notable, with over 25,600 shares sold in the last 90 days, which could indicate a lack of confidence from those closest to the company.
  • The company has a negative return on equity of 15.06%, which means it is not generating profit from its equity, a potential red flag for investors.
  • Despite revenue growth, the company reported a negative net margin of 12.08%, indicating that it is not yet profitable, which could deter risk-averse investors.
  • Market volatility, as indicated by a beta of 1.17, suggests that the stock may experience larger price swings compared to the overall market, increasing investment risk.

MDB Forecast - Frequently Asked Questions

According to the research reports of 29 Wall Street equities research analysts, the average twelve-month stock price forecast for MongoDB is $366.14, with a high forecast of $430.00 and a low forecast of $220.00.

29 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MongoDB in the last year. There are currently 2 sell ratings, 5 hold ratings, 21 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" MDB shares.

According to analysts, MongoDB's stock has a predicted upside of 49.06% based on their 12-month stock forecasts.

Over the previous 90 days, MongoDB's stock had 1 upgrade and 1 downgrade by analysts.

Analysts like MongoDB more than other "computer and technology" companies. The consensus rating score for MongoDB is 2.72 while the average consensus rating score for "computer and technology" companies is 2.69. Learn more on how MDB compares to other companies.


This page (NASDAQ:MDB) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners